Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDK.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDK.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LS.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.8.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.8.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.1.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDD.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDD.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDNNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDNNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.1 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
BA.5.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.49.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.49.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.3.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.3.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GE.1.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GE.1.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.58.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.58.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.11.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.11.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GJ.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used